FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / PLoS One / Detection of vasculogenic mimicry in equine ocular, oronasal...
PloS one2026; 21(1); e0328584; doi: 10.1371/journal.pone.0328584

Detection of vasculogenic mimicry in equine ocular, oronasal, and genital squamous cell carcinoma.

Abstract: Squamous cell carcinoma (SCC) is the most common malignant tumor disease in horses. It predominantly affects the ocular, oronasal, and anogenital region. Equine SCC is difficult to treat, also because important aspects of SCC development and metastasis are still unclear. We previously provided evidence that equine SCC cells can adopt a stem cell-like phenotype as a hallmark of malignant progression. Here, we investigated whether equine SCCs harbor endothelial-like tumor cells that form an alternative network of pseudo-vessels better known as vasculogenic mimicry (VM). Following histopathological diagnosis, 43 equine SCCs or precursor lesions (15 ocular, 14 genital, 14 oronasal tumors) were PCR-screened for equine papillomavirus (EcPV) infection. Subsequently, formalin-fixed paraffin-embedded (FFPE)-sections of all tumors were analyzed by Periodic Acid-Schiff (PAS) reaction and immunohistochemical (IHC) staining for endothelial cell marker CD31. Obtained micrographs were evaluated by a scientific board to unanimously identify sections of intact tumor tissue displaying PAS-positive, CD31-negative lumens harboring erythrocytes. Thirteen lesions exhibiting these features were subjected to triple immunofluorescence (IF) staining for CD31, pan-cytokeratin (KRT) and type 4 collagen (Col4) or alpha smooth muscle actin (αSMA) to confirm the presence of VM, and to determine whether pericytes have a role in this phenomenon. All genital and 50% of oronasal lesions scored positive for EcPV type 2, whilst ocular lesions tested negative. One mandibular SCC harbored EcPV type 5. Six genital, three oronasal, and four ocular tumors unambiguously exhibited VM as revealed by CD31-/PAS+ vessel-like structures containing erythrocytes, the detection of CD31-negative cells lining their lumens, and the presence of Col4 and αSMA in this lining. Detection of these two proteins in the context of VM suggests that VM-forming cancer cells recruit pericytes to enhance channel formation and stability. To our knowledge, this is the first report providing evidence of VM in equine cancer, and more generally, SCC in animals.
Copyright: © 2026 Schwarz et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Get Full Text
Publication Date: 2026-01-05 PubMed ID: 41490689PubMed Central: PMC12768272DOI: 10.1371/journal.pone.0328584Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

Overview

  • This study investigates the presence of vasculogenic mimicry (VM), a process where tumor cells form vessel-like networks, in equine squamous cell carcinoma (SCC) affecting ocular, oronasal, and genital regions.
  • The researchers identify VM structures in these tumors and examine their cellular characteristics, including the involvement of pericytes. This is the first report showing VM in animal SCCs.

Background and Objectives

  • Squamous cell carcinoma (SCC) is the most common malignant tumor in horses, frequently affecting the eyes, nasal/oral cavities, and genital areas.
  • Equine SCC is challenging to treat because mechanisms underlying its progression and spread (metastasis) are not fully understood.
  • Previously, researchers found that equine SCC cells can adopt stem cell-like traits, which is linked to malignancy.
  • The current study aims to investigate whether equine SCC tumors contain “endothelial-like” tumor cells that form alternative vascular networks known as vasculogenic mimicry (VM).
  • VM is different from traditional blood vessels because it is formed by tumor cells mimicking endothelial cells, creating channels that can carry blood and support tumor growth.

Methods

  • Tumor Samples:
    • 43 equine SCC tumors or precursors were analyzed: 15 ocular, 14 genital, and 14 oronasal lesions.
  • Equine Papillomavirus Screening:
    • Polymerase chain reaction (PCR) was used to detect equine papillomavirus (EcPV) DNA in tumors, as viral infection can be linked with SCC development.
  • Histological and Immunohistochemical Analysis:
    • Tumor tissue sections were stained with Periodic Acid-Schiff (PAS) to highlight basement membrane-like structures.
    • Immunohistochemistry (IHC) staining for the endothelial marker CD31 was performed to distinguish true blood vessels (CD31-positive) from VM channels (CD31-negative but PAS-positive).
    • Scientific experts examined the stained tissue micrographs to identify lumens that contained red blood cells but lacked endothelial marker CD31, indicative of VM.
  • Triple Immunofluorescence Staining:
    • For the lesions exhibiting VM-like features, triple staining was performed for CD31, pan-cytokeratin (KRT, a tumor cell marker), and either type IV collagen (Col4) or alpha smooth muscle actin (αSMA).
    • This confirmed the presence of VM by showing tumor cells lining vessel-like structures without endothelial markers but with basement membrane proteins and pericyte markers.

Results

  • Equine Papillomavirus Findings:
    • EcPV type 2 was detected in all genital tumors and half of the oronasal tumors but was negative in ocular tumors.
    • One mandibular SCC carried EcPV type 5.
  • Vasculogenic Mimicry Identification:
    • 13 lesions showed PAS-positive, CD31-negative lumens containing erythrocytes, suggesting functional VM vessels.
    • These included 6 genital, 3 oronasal, and 4 ocular tumors.
  • Immunofluorescence Confirmation:
    • CD31-negative cells lining VM channels were positive for pan-cytokeratin, confirming their epithelial tumor origin rather than endothelial.
    • Type IV collagen and αSMA staining indicated the presence of basement membrane components and recruitment of pericytes in these VM structures.
    • The involvement of pericytes suggests that tumor cells may stabilize these pseudo-vessels similarly to real blood vessels.

Conclusions and Significance

  • This is the first study to directly demonstrate vasculogenic mimicry in equine cancers, specifically SCCs, as well as in animal squamous cell carcinoma generally.
  • VM may be an important mechanism employed by equine SCC tumors to support blood supply and contribute to malignant progression.
  • The finding that pericytes are recruited to VM channels suggests possible pathways for tumor vascularization distinct from classical angiogenesis.
  • Better understanding of VM in equine SCC could lead to improved treatment strategies targeting these alternative vascular structures.
  • These discoveries enhance the broader knowledge of tumor biology and malignancy in veterinary medicine and may offer insights relevant to human cancers as well.

Cite This Article

APA
Schwarz S, Kummer S, Klang A, Walter I, Nell B, Brandt S. (2026). Detection of vasculogenic mimicry in equine ocular, oronasal, and genital squamous cell carcinoma. PLoS One, 21(1), e0328584. https://doi.org/10.1371/journal.pone.0328584

Publication

PloS one
ISSN: 1932-6203
NlmUniqueID: 101285081
Country: United States
Language: English
Volume: 21
Issue: 1
Pages: e0328584
PII: e0328584

Researcher Affiliations

Schwarz, Sophie
  • Department for Small Animals and Horses, University of Veterinary Medicine, Vienna, Austria.
Kummer, Stefan
  • VetCore Facility for Research, University of Veterinary Medicine, Vienna, Austria.
Klang, Andrea
  • Institute of Pathology, Department of Biological Sciences and Pathobiology, University of Veterinary Medicine, Vienna, Austria.
Walter, Ingrid
  • VetCore Facility for Research, University of Veterinary Medicine, Vienna, Austria.
  • Institute of Morphology, Department of Biological Sciences and Pathobiology, University of Veterinary Medicine, Vienna, Austria.
Nell, Barbara
  • Department for Small Animals and Horses, University of Veterinary Medicine, Vienna, Austria.
Brandt, Sabine
  • Research Group Oncology, Division of Equine Surgery, Department for Small Animal and Horses, University of Veterinary Medicine, Vienna, Austria.

MeSH Terms

  • Animals
  • Horses
  • Carcinoma, Squamous Cell / pathology
  • Carcinoma, Squamous Cell / veterinary
  • Carcinoma, Squamous Cell / blood supply
  • Carcinoma, Squamous Cell / metabolism
  • Eye Neoplasms / pathology
  • Eye Neoplasms / veterinary
  • Eye Neoplasms / blood supply
  • Eye Neoplasms / metabolism
  • Horse Diseases / pathology
  • Horse Diseases / metabolism
  • Horse Diseases / virology
  • Neovascularization, Pathologic / pathology
  • Mouth Neoplasms / pathology
  • Mouth Neoplasms / veterinary
  • Mouth Neoplasms / blood supply
  • Mouth Neoplasms / metabolism
  • Nose Neoplasms / pathology
  • Nose Neoplasms / veterinary
  • Nose Neoplasms / blood supply
  • Female
  • Male
  • Papillomavirus Infections / veterinary
  • Papillomavirus Infections / pathology
  • Genital Neoplasms, Female / pathology
  • Genital Neoplasms, Female / veterinary

Conflict of Interest Statement

The authors have declared that no competing interests exist.

References

This article includes 64 references
  1. Dayyani F, Etzel CJ, Liu M, Ho C-H, Lippman SM, Tsao AS. Meta-analysis of the impact of human papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC).. Head Neck Oncol 2010;2:15.
    doi: 10.1186/1758-3284-2-15pmc: PMC2908081pubmed: 20587061google scholar: lookup
  2. Claveau J, Archambault J, Ernst DS, Giacomantonio C, Limacher JJ, Murray C. Multidisciplinary management of locally advanced and metastatic cutaneous squamous cell carcinoma.. Curr Oncol 2020;27(4):e399–407.
    doi: 10.3747/co.27.6015pmc: PMC7467796pubmed: 32905333google scholar: lookup
  3. Fania L, Didona D, Di Pietro FR, Verkhovskaia S, Morese R, Paolino G. Cutaneous squamous cell carcinoma: from pathophysiology to novel therapeutic approaches.. biomedicines 2021;9(2):171.
    doi: 10.3390/biomedicines9020171pmc: PMC7916193pubmed: 33572373google scholar: lookup
  4. Guech-Ongey M, Engels EA, Goedert JJ, Biggar RJ, Mbulaiteye SM. Elevated risk for squamous cell carcinoma of the conjunctiva among adults with AIDS in the United States.. Int J Cancer 2008;122(11):2590–3.
    doi: 10.1002/ijc.23384pubmed: 18224690google scholar: lookup
  5. Gutzmer R, Wiegand S, Kölbl O, Wermker K, Heppt M, Berking C. Actinic keratosis and cutaneous squamous cell carcinoma.. Dtsch Arztebl Int 2019;116(37):616–26.
    doi: 10.3238/arztebl.2019.0616pmc: PMC6819699pubmed: 32048593google scholar: lookup
  6. Kallini JR, Hamed N, Khachemoune A. Squamous cell carcinoma of the skin: epidemiology, classification, management, and novel trends.. Int J Dermatol 2015;54(2):130–40.
    doi: 10.1111/ijd.12553pubmed: 25428226google scholar: lookup
  7. Marur S, Forastiere AA. Head and Neck Squamous Cell Carcinoma: Update on Epidemiology, Diagnosis, and Treatment.. Mayo Clin Proc 2016;91(3):386–96.
    doi: 10.1016/j.mayocp.2015.12.017pubmed: 26944243google scholar: lookup
  8. Strafuss AC. Squamous cell carcinoma in horses.. J Am Vet Med Assoc 1976;168(1):61–2.
    doi: 10.2460/javma.1976.168.01.61pubmed: 1245449google scholar: lookup
  9. Scott DW, Miller WHJ. Squamous cell carcinoma.. .
  10. Knottenbelt DC. Squamous cell carcinoma.. .
  11. Pascoe RR, Knottenbelt DC. Squamous cell carcinoma.. .
  12. van den Top JGB, de Heer N, Klein WR, Ensink JM. Penile and preputial squamous cell carcinoma in the horse: a retrospective study of treatment of 77 affected horses.. Equine Vet J 2008;40(6):533–7.
    doi: 10.2746/042516408X281171pubmed: 18487102google scholar: lookup
  13. Scase T, Brandt S, Kainzbauer C, Sykora S, Bijmholt S, Hughes K. Equus caballus papillomavirus-2 (EcPV-2): an infectious cause for equine genital cancer?.. Equine Vet J 2010;42(8):738–45.
    doi: 10.1111/j.2042-3306.2010.00311.xpubmed: 21039805google scholar: lookup
  14. Sykora S, Brandt S. Papillomavirus infection and squamous cell carcinoma in horses.. Vet J 2017;223:48–54.
    doi: 10.1016/j.tvjl.2017.05.007pubmed: 28671071google scholar: lookup
  15. Knight CG, Dunowska M, Munday JS, Peters-Kennedy J, Rosa BV. Comparison of the levels of Equus caballus papillomavirus type 2 (EcPV-2) DNA in equine squamous cell carcinomas and non-cancerous tissues using quantitative PCR.. Vet Microbiol 2013;166(1–2):257–62.
    doi: 10.1016/j.vetmic.2013.06.004pubmed: 23845733google scholar: lookup
  16. Sykora S, Jindra C, Hofer M, Steinborn R, Brandt S. Equine papillomavirus type 2: An equine equivalent to human papillomavirus 16?. Vet J 2017;225:3–8.
    doi: 10.1016/j.tvjl.2017.04.014pubmed: 28720295google scholar: lookup
  17. Bellone RR, Liu J, Petersen JL, Mack M, Singer-Berk M, Drögemüller C. A missense mutation in damage-specific DNA binding protein 2 is a genetic risk factor for limbal squamous cell carcinoma in horses. Int J Cancer 2017;141(2):342–53.
    doi: 10.1002/ijc.30744pubmed: 28425625google scholar: lookup
  18. Lassaline M, Cranford TL, Latimer CA, Bellone RR. Limbal squamous cell carcinoma in Haflinger horses. Vet Ophthalmol 2015;18(5):404–8.
    doi: 10.1111/vop.12229pubmed: 25312447google scholar: lookup
  19. Singer-Berk M, Knickelbein KE, Vig S, Liu J, Bentley E, Nunnery C. Genetic risk for squamous cell carcinoma of the nictitating membrane parallels that of the limbus in Haflinger horses. Anim Genet 2018;49(5):457–60.
    doi: 10.1111/age.12695pubmed: 29999543google scholar: lookup
  20. Yuan S, Norgard RJ, Stanger BZ. Cellular Plasticity in Cancer. Cancer Discov 2019;9(7):837–51.
    doi: 10.1158/2159-8290.CD-19-0015pmc: PMC6606363pubmed: 30992279google scholar: lookup
  21. Chen C, Zimmermann M, Tinhofer I, Kaufmann AM, Albers AE. Epithelial-to-mesenchymal transition and cancer stem(-like) cells in head and neck squamous cell carcinoma. Cancer Lett 2013;338(1):47–56.
    doi: 10.1016/j.canlet.2012.06.013pubmed: 22771535google scholar: lookup
  22. Oshimori N. Cancer stem cells and their niche in the progression of squamous cell carcinoma. Cancer Sci 2020;111(11):3985–92.
    doi: 10.1111/cas.14639pmc: PMC7648029pubmed: 32888236google scholar: lookup
  23. Baum B, Settleman J, Quinlan MP. Transitions between epithelial and mesenchymal states in development and disease. Semin Cell Dev Biol 2008;19(3):294–308.
    doi: 10.1016/j.semcdb.2008.02.001pubmed: 18343170google scholar: lookup
  24. Dongre A, Weinberg RA. New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer. Nat Rev Mol Cell Biol 2019;20(2):69–84.
    doi: 10.1038/s41580-018-0080-4pubmed: 30459476google scholar: lookup
  25. Yang J, Weinberg RA. Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell 2008;14(6):818–29.
    doi: 10.1016/j.devcel.2008.05.009pubmed: 18539112google scholar: lookup
  26. Babaei G, Aziz SG-G, Jaghi NZZ. EMT, cancer stem cells and autophagy; The three main axes of metastasis. Biomed Pharmacother 2021;133:110909.
    doi: 10.1016/j.biopha.2020.110909pubmed: 33227701google scholar: lookup
  27. Dawood S, Austin L, Cristofanilli M. Cancer stem cells: implications for cancer therapy. Oncology (Williston Park) 2014;28(12):1101–7, 1110.
    pubmed: 25510809
  28. Elkashty OA, Abu Elghanam G, Su X, Liu Y, Chauvin PJ, Tran SD. Cancer stem cells enrichment with surface markers CD271 and CD44 in human head and neck squamous cell carcinomas. Carcinogenesis 2020;41(4):458–66.
    doi: 10.1093/carcin/bgz182pmc: PMC7298622pubmed: 31742606google scholar: lookup
  29. Keysar SB, Le PN, Miller B, Jackson BC, Eagles JR, Nieto C. Regulation of Head and Neck Squamous Cancer Stem Cells by PI3K and SOX2. J Natl Cancer Inst 2016;109(1):djw189.
    doi: 10.1093/jnci/djw189pmc: PMC5025278pubmed: 27634934google scholar: lookup
  30. Ben-Porath I, Thomson MW, Carey VJ, Ge R, Bell GW, Regev A. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet 2008;40(5):499–507.
    doi: 10.1038/ng.127pmc: PMC2912221pubmed: 18443585google scholar: lookup
  31. Maniotis AJ, Folberg R, Hess A, Seftor EA, Gardner LM, Pe’er J. Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol 1999;155(3):739–52.
    doi: 10.1016/S0002-9440(10)65173-5pmc: PMC1866899pubmed: 10487832google scholar: lookup
  32. Lugassy C, Zadran S, Bentolila LA, Wadehra M, Prakash R, Carmichael ST. Angiotropism, pericytic mimicry and extravascular migratory metastasis in melanoma: an alternative to intravascular cancer dissemination. Cancer Microenviron 2014;7(3):139–52.
    doi: 10.1007/s12307-014-0156-4pmc: PMC4275501pubmed: 25304454google scholar: lookup
  33. Massimini M, Romanucci M, De Maria R, Della Salda L. An Update on Molecular Pathways Regulating Vasculogenic Mimicry in Human Osteosarcoma and Their Role in Canine Oncology. Front Vet Sci 2021;8:722432.
    doi: 10.3389/fvets.2021.722432pmc: PMC8494780pubmed: 34631854google scholar: lookup
  34. Thijssen VL, Paulis YW, Nowak-Sliwinska P, Deumelandt KL, Hosaka K, Soetekouw PM. Targeting PDGF-mediated recruitment of pericytes blocks vascular mimicry and tumor growth. J Pathol 2018;246(4):447–58.
    doi: 10.1002/path.5152pmc: PMC6587443pubmed: 30101525google scholar: lookup
  35. Vartanian A, Stepanova E, Grigorieva I, Solomko E, Belkin V, Baryshnikov A. Melanoma vasculogenic mimicry capillary-like structure formation depends on integrin and calcium signaling. Microcirculation 2011;18(5):390–9.
    doi: 10.1111/j.1549-8719.2011.00102.xpubmed: 21438962google scholar: lookup
  36. Yang JP, Liao YD, Mai DM, Xie P, Qiang YY, Zheng LS. Tumor vasculogenic mimicry predicts poor prognosis in cancer patients: a meta-analysis. Angiogenesis 2016;19(2):191–200.
    doi: 10.1007/s10456-016-9500-2pubmed: 26899730google scholar: lookup
  37. Liu Z-L, Chen H-H, Zheng L-L, Sun L-P, Shi L. Angiogenic signaling pathways and anti-angiogenic therapy for cancer. Signal Transduct Target Ther 2023;8(1):198.
    doi: 10.1038/s41392-023-01460-1pmc: PMC10175505pubmed: 37169756google scholar: lookup
  38. Guiraldelli GG, Prado MCM, de F Lainetti P, Leis-Filho AF, Kobayashi PE, Cury SS. Pathways Involved in the Development of Vasculogenic Mimicry in Canine Mammary Carcinoma Cell Cultures. J Comp Pathol 2022;192:50–60.
    doi: 10.1016/j.jcpa.2022.01.001pubmed: 35305714google scholar: lookup
  39. Nordio L, Fattori S, Vascellari M, Giudice C. Evidence of vasculogenic mimicry in a palpebral melanocytoma in a dog. J Comp Pathol 2018;162:43–6.
    doi: 10.1016/j.jcpa.2018.06.003pubmed: 30060841google scholar: lookup
  40. Strohmayer C, Klang A, Kummer S, Walter I, Jindra C, Weissenbacher-Lang C. Tumor cell plasticity in equine papillomavirus-positive versus-negative squamous cell carcinoma of the head and neck. Pathogens 2022;11(2):266.
    doi: 10.3390/pathogens11020266pmc: PMC8875230pubmed: 35215208google scholar: lookup
  41. Miglinci L, Reicher P, Nell B, Koch M, Jindra C, Brandt S. Detection of equine papillomaviruses and gamma-herpesviruses in equine squamous cell carcinoma. Pathogens 2023;12(2):179.
    doi: 10.3390/pathogens12020179pmc: PMC9958655pubmed: 36839451google scholar: lookup
  42. Anneroth G, Batsakis J, Luna M. Review of the literature and a recommended system of malignancy grading in oral squamous cell carcinomas. Scand J Dent Res 1987;95(3):229–49.
    doi: 10.1111/j.1600-0722.1987.tb01836.xpubmed: 3299675google scholar: lookup
  43. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011;144(5):646–74.
    doi: 10.1016/j.cell.2011.02.013pubmed: 21376230google scholar: lookup
  44. Mani SA, Guo W, Liao M-J, Eaton EN, Ayyanan A, Zhou AY. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008;133(4):704–15.
    doi: 10.1016/j.cell.2008.03.027pmc: PMC2728032pubmed: 18485877google scholar: lookup
  45. Armando F, Mecocci S, Orlandi V, Porcellato I, Cappelli K, Mechelli L. Investigation of the Epithelial to Mesenchymal Transition (EMT) Process in Equine Papillomavirus-2 (EcPV-2)-Positive Penile Squamous Cell Carcinomas. Int J Mol Sci 2021;22(19):10588.
    doi: 10.3390/ijms221910588pmc: PMC8508821pubmed: 34638929google scholar: lookup
  46. Rushton JO, Kolodziejek J, Tichy A, Nowotny N, Nell B. Clinical course of ophthalmic findings and potential influence factors of herpesvirus infections: 18 month follow-up of a closed herd of lipizzaners. PLoS One 2013;8(11):e79888.
    doi: 10.1371/journal.pone.0079888pmc: PMC3835803pubmed: 24278206google scholar: lookup
  47. Hujanen R, Almahmoudi R, Karinen S, Nwaru BI, Salo T, Salem A. Vasculogenic mimicry: a promising prognosticator in head and neck squamous cell carcinoma and esophageal cancer? a systematic review and meta-analysis. Cells 2020;9(2):507.
    doi: 10.3390/cells9020507pmc: PMC7072765pubmed: 32102317google scholar: lookup
  48. Hujanen R, Almahmoudi R, Salo T, Salem A. Comparative Analysis of Vascular Mimicry in Head and Neck Squamous Cell Carcinoma: In Vitro and In Vivo Approaches. Cancers (Basel) 2021;13(19):4747.
    doi: 10.3390/cancers13194747pmc: PMC8507545pubmed: 34638234google scholar: lookup
  49. Salem A, Salo T. Vasculogenic mimicry in head and neck squamous cell carcinoma-time to take notice. Front Oral Health 2021;2:666895.
    doi: 10.3389/froh.2021.666895pmc: PMC8757801pubmed: 35048009google scholar: lookup
  50. Liu S-Y, Chang L-C, Pan L-F, Hung Y-J, Lee C-H, Shieh Y-S. Clinicopathologic significance of tumor cell-lined vessel and microenvironment in oral squamous cell carcinoma. Oral Oncol 2008;44(3):277–85.
    doi: 10.1016/j.oraloncology.2007.02.007pubmed: 17475541google scholar: lookup
  51. Valdivia A, Mingo G, Aldana V, Pinto MP, Ramirez M, Retamal C. Fact or Fiction, It Is Time for a Verdict on Vasculogenic Mimicry?. Front Oncol 2019;9:680.
    doi: 10.3389/fonc.2019.00680pmc: PMC6688045pubmed: 31428573google scholar: lookup
  52. Chang YS, di Tomaso E, McDonald DM, Jones R, Jain RK, Munn LL. Mosaic blood vessels in tumors: frequency of cancer cells in contact with flowing blood. Proc Natl Acad Sci U S A 2000;97(26):14608–13.
    doi: 10.1073/pnas.97.26.14608pmc: PMC18966pubmed: 11121063google scholar: lookup
  53. Folberg R, Hendrix MJ, Maniotis AJ. Vasculogenic mimicry and tumor angiogenesis. Am J Pathol 2000;156(2):361–81.
    doi: 10.1016/S0002-9440(10)64739-6pmc: PMC1850026pubmed: 10666364google scholar: lookup
  54. Hendrix MJC, Seftor EA, Hess AR, Seftor REB. Vasculogenic mimicry and tumour-cell plasticity: lessons from melanoma. Nat Rev Cancer 2003;3(6):411–21.
    doi: 10.1038/nrc1092pubmed: 12778131google scholar: lookup
  55. Hendrix MJC, Seftor EA, Seftor REB, Chao J-T, Chien D-S, Chu Y-W. Tumor cell vascular mimicry: Novel targeting opportunity in melanoma. Pharmacol Ther 2016;159:83–92.
    doi: 10.1016/j.pharmthera.2016.01.006pmc: PMC4779708pubmed: 26808163google scholar: lookup
  56. Seftor EA, Meltzer PS, Schatteman GC, Gruman LM, Hess AR, Kirschmann DA. Expression of multiple molecular phenotypes by aggressive melanoma tumor cells: role in vasculogenic mimicry. Crit Rev Oncol Hematol 2002;44(1):17–27.
    doi: 10.1016/s1040-8428(01)00199-8pubmed: 12398997google scholar: lookup
  57. Marelli-Berg FM, Clement M, Mauro C, Caligiuri G. An immunologist’s guide to CD31 function in T-cells. J Cell Sci 2013;126(Pt 11):2343–52.
    doi: 10.1242/jcs.124099pubmed: 23761922google scholar: lookup
  58. Saitoh M. Involvement of partial EMT in cancer progression. J Biochem 2018;164(4):257–64.
    doi: 10.1093/jb/mvy047pubmed: 29726955google scholar: lookup
  59. Liao C, Wang Q, An J, Long Q, Wang H, Xiang M. Partial EMT in squamous cell carcinoma: a snapshot. Int J Biol Sci 2021;17(12):3036–47.
    doi: 10.7150/ijbs.61566pmc: PMC8375241pubmed: 34421348google scholar: lookup
  60. Franke WW, Schmid E, Osborn M, Weber K. Intermediate-sized filaments of human endothelial cells. J Cell Biol 1979;81(3):570–80.
    doi: 10.1083/jcb.81.3.570pmc: PMC2110384pubmed: 379021google scholar: lookup
  61. Miettinen M, Fetsch JF. Distribution of keratins in normal endothelial cells and a spectrum of vascular tumors: implications in tumor diagnosis. Hum Pathol 2000;31(9):1062–7.
    doi: 10.1053/hupa.2000.9843pubmed: 11014572google scholar: lookup
  62. Kornfield TE, Newman EA. Regulation of blood flow in the retinal trilaminar vascular network. J Neurosci 2014;34(34):11504–13.
    doi: 10.1523/JNEUROSCI.1971-14.2014pmc: PMC4138352pubmed: 25143628google scholar: lookup
  63. Stratman AN, Malotte KM, Mahan RD, Davis MJ, Davis GE. Pericyte recruitment during vasculogenic tube assembly stimulates endothelial basement membrane matrix formation. Blood 2009;114(24):5091–101.
    doi: 10.1182/blood-2009-05-222364pmc: PMC2788982pubmed: 19822899google scholar: lookup
  64. Alibardi L. Keratinization and Cornification are not equivalent processes but keratinization in fish and amphibians evolved into cornification in terrestrial vertebrates. Exp Dermatol 2022;31(5):794–9.
    doi: 10.1111/exd.14525pubmed: 35007368google scholar: lookup

Citations

This article has been cited 0 times.
Subscribe to our newsletter
Join 99,048 horse owners like you who receive our email updates on horse health and nutrition.